TD Cowen analyst Steve Scala maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $430 to $500.
TD Cowen analyst Steve Scala maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $430 to $500.